Figure 6
Immonohistochemical analysis of bone remodeling markers during the boneregeneration process. Percentile ranks of immunolabeling forOsteoprotegerin (OPG), Receptor activator of nuclear factor kappa-B ligand(RANKL), and Osteocalcin (OC) at 7 and 14 days after surgery, in bonedefects generated by drilling (Drill) or piezosuregry (Piezo). No statisticallysignificant differences were found across all time points(n = 3).